Abstract
L-arginine supplemented immunonutrition (IM) enteral formulas have been designed to optimize outcomes in critically ill patients, and routine use is suggested post-operatively in the surgical intensive care unit (ICU). The objective was to compare health outcomes between different IM formulas.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
